MedPath

Study of the ANI Validity on Evaluation of Nociception in State of Hypnosis

Not Applicable
Completed
Conditions
Healthy
Registration Number
NCT02302313
Lead Sponsor
University Hospital, Brest
Brief Summary

Healthy subjects should assess pain on a numerical scale (EN), during painful skin stimuli of variable intensity delivered by a CO2 laser used at the power of 0.3 W, known for its safety. ANI (Analgesia Nociception Index) will be raised simultaneously. This sequence will be made on subjects at rest and in a state of hypnosis using the technique of "remembering a pleasant memory" and the ideo-sensory technique of "protective glove".

The average value of the ANI will be compared to the value of the EVN of pain intensity.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • Knowledge of the state of hypnosis
  • Healthy volunteers
  • Capable adults
  • Free and informed consent
Exclusion Criteria
  • Heart diseases
  • Medication affecting the heart rate
  • Medication affecting the skin sensitivity

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
EVN value of pain intensity versus average value of the ANIANI average value : measured continuously for 60 seconds after the painful stimulation. EVN value : raised a few seconds after the painful stimulation

ANI value (0 to 100, without unit of measure) recorded continuously for 60 seconds after the painful stimulation compared to the EVN value of the pain intensity, from zero to ten (numerical verval scale), and this for each of 6 painful stimuli intensities of each three consecutive phases of the study.

Secondary Outcome Measures
NameTimeMethod
EVN value of the arduousness of pain perception versus ANI valueANI average value : measured continuously for 60 seconds after the painful stimulation. EVN value : raised a few seconds after the painful stimulation

EVN value of the arduousness of pain perception, from zéro to ten, for a stimulation intensity, depending on the phase of the study, compared to the ANI.

Trial Locations

Locations (1)

Centre Hospitalier Privé Saint-Grégoire

🇫🇷

Saint-Grégoire, France

Centre Hospitalier Privé Saint-Grégoire
🇫🇷Saint-Grégoire, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.